Author

B. C. Calverley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Pickard· 2 shared J. Chang· 1 shared K. E. Kadler· 1 shared K. Kadler· 1 shared R. Garva· 1 shared Y. Lu· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Pickard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivJan 31, 2021

Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells

A. Pickard, B. C. Calverley, J. Chang…·K. E. Kadler

This study identifies 35 FDA-approved drugs that reduce SARS-CoV-2 replication in human cells, including amodiaquine and vitamin D3.

DOI 10.1371/journal.ppat.1009840

humanexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivMay 17, 2020

Dynamic protein quantification (DyProQ) of procollagen-I by CRISPR-Cas9 NanoLucIferase tagging

B. C. Calverley, K. Kadler, A. Pickard

This paper introduces DyProQ, a method using CRISPR-Cas9 and NanoLuciferase to quantify procollagen-I dynamically, identifying potential drug candidates for fibrotic and degenerative diseases.

DOI 10.3390/cells9092070

humanproteomics

𝕏 PostBluesky